Preconditioning effects of the anesthetic administered to the donor on grafted kidney function in living donor kidney transplantation recipients

Minerva Anestesiologica

Volumn 79, Issue 5, 2013, Pages 504-514

  Lee, J H ^a   Joo, D J ^a   Kim, J M ^a   Park, J H ^a   Kim, Y S ^a   Koo, Bon Nyeo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Anesthetics, general; Ischemic preconditioning; Kidney transplantation; Living donors

Indexed keywords

CREATININE; DESFLURANE; ISOFLURANE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROPOFOL; SEVOFLURANE;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; INHALATION ANESTHESIA; ISCHEMIC PRECONDITIONING; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; RETROSPECTIVE STUDY;

ADULT; ANESTHETICS; CREATININE; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LIPOCALINS; LIVING DONORS; MALE; PROSPECTIVE STUDIES; REPERFUSION INJURY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84880158975     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004;364:1814-27. (Pubitemid 39488068)
2. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005;365:417-30. (Pubitemid 40179230)
3. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004;114:5-14. (Pubitemid 39071636)
4. Minguet G, Joris J, Lamy M: Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics? Eur J Anaesthesiol 2007;24:733-45. (Pubitemid 47237691)
5. Raphael J, Zuo Z, Abedat S, Beeri R, Gozal Y. Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin. Anesthesiology 2008;108:415-25. (Pubitemid 351304235)
6. An J, Bosnjak ZJ, Jiang MT. Myocardial protection by isoflurane preconditioning preserves Ca2+ cycling proteins independent of sarcolemmal and mitochondrial KATP channels. Anesth Analg 2007;105:1207-13 (Pubitemid 350303917)
7. Fräßdorf J, Borowski A, Ebel D, Feindt P, Hermes M, Meemann T et al. Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery. J Thorac Cardiovasc Surg 2009;137:1436-42
8. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004;101:299-310. (Pubitemid 38988484)
9. Hashiguchi H, Morooka H, Miyoshi H, Matsumoto M, Koji T, Sumikawa K. Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK. Anesth Analg 2005;101:1584-9. (Pubitemid 41720601)
10. Lee HT, Chen SW, Doetschman TC, Deng C, D'Agati VD, Kim M. Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-β1 pathway. Am J Physiol Renal Physiol 2008;295:F128-F36.
11. Lee HT, Kim M, Kim M, Kim N, Billings FT, D'Agati VD et al. Isoflurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice. Am J Physiol Renal Physiol 2007;293:F713-F22.
12. Zhang L, Huang H, Cheng J, Liu J, Zhao H, Vizcaychipi MP et al. Pre-treatment with isoflurane ameliorates renal ischemic-reperfusion injury in mice. Life Sci 2011;88:1102-7.
13. Lee HT, Ota-Setlik A, Fu Y, Nasr SH, Emala CW. Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 2004;101:1313-24. (Pubitemid 39564987)
14. Kellum JA, Bellomo R, Ronco C. Definition and classification of acute kidney injury. Nephron. Clin pract 2008;109:c182-c7.
15. Obal D, Rascher K, Favoccia C, Dettwiler S, Schlack W. Post-conditioning by a short administration of desflurane reduced renal reperfusion injury after differing of ischaemia times in rats. Br J Anaesth 2006;97:783-91. (Pubitemid 44823662)
16. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 2003;98:1315-27. (Pubitemid 36622462)
17. Yuzbasioglu MF, Aykas A, Kurutas EB, Sahinkanat T. Protective effects of propofol against ischemia/reperfusion injury in rat kidneys. Ren fail 2010;32:578-83.
18. Wang Hh, Zhou Hy, Chen Cc, Zhang XI, Cheng G. Propofol attenuation of renal ischemia/reperfusion injury involves heme oxygenase-1. Acta Pharmacologica Sinica 2007;28:1175-80. (Pubitemid 47197767)
19. Yuzer H, Yuzbasioglu MF, Ciralik H, Kurutas EB, Ozkan OV, Bulbuloglu E et al. Effects of intravenous anesthetics on renal ischemia/reperfusion injury. Ren fail 2009;31:290-6.
20. Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 2008;52:595-605.
21. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009;54:1012-24.
22. Parikh CR, Jani A, Mishra J, Ma Q, Kelly C, Barasch J et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006;6:1639-45. (Pubitemid 43945804)
23. Hall IE, Yarlagadda SG, Coca SG, Wang Z, Doshi M, Devarajan P et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol 2010;21:189-97.
24. Bataille A, Abbas S, Semoun O, Bourgeois E, Marie O, Bonnet F et al. Plasma neutrophil gelatinase-associated lipocalin in kidney transplantation and early renal function prediction. Transplantation 2011;92:1024-30.
25. Hollmen ME, Kyllnen LE, Inkinen KA, Lalla ML, Salmela KT. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. Kidney Int 2011;79:89-98.
26. Lebkowska U, Malyszko J, Lebkowska A, Koc-Zorawska E, Lebkowski W, Malyszko JS et al. Neutrophil gelatinase-associated lipocalin and cystatin c could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study. Transplant Proc 2009;41:154-7.
27. Kusaka M, Kuroyanagi Y, Mori T, Nagaoka K, Sasaki H, Maruyama T et al. Serum neutrophil gelatinase-associated lipocalin as a predictor of organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. Cell transplant 2008;17:129-34. (Pubitemid 351551388)
28. Irish WD, McCollum DA, Tesi RJ, Owen AB, Brennan DC, Bailly JE et al. Nomogram for predicting the likelihood of delayed graft function in adult cadevaric renal transplant recipients. J Am Soc Nephrol 2003;14:2967-74. (Pubitemid 37305660)